Eriksson, R., Broberg, B. V., Ishøy, P. L., Bak, N., Andersen, U. B., Jørgensen, N. R., . . . Ebdrup, B. H. (2019). Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Front Psychiatry.
Citação norma ChicagoEriksson, Robert, Brian V. Broberg, Pelle L. Ishøy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jørgensen, Filip K. Knop, and Bjørn H. Ebdrup. "Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide On Bone Turnover Markers and Bone Mineral Density." Front Psychiatry 2019.
MLA citiranjeEriksson, Robert, et al. "Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide On Bone Turnover Markers and Bone Mineral Density." Front Psychiatry 2019.